Cargando…
MON-902 Etomidate - an Under Utilized but Safe and Efficacious Drug to Treat Acute Severe Cushing’s Syndrome- Case Reports of Ectopic ACTH Syndrome from Neuroendocrine Malignancies
Background: Intravenous etomidate infusion, in non-hypnotic doses, rapidly lowers cortisol levels by blocking 11-beta hydroxylation of deoxycortisol to inhibit cortisol production. It is an underutilized drug due to concerns of excess sedation and ICU monitoring. Clinical Case 1: A 44 year-old femal...
Autores principales: | Cherian, Elena Thampy, Naik, Sapna, Cillo, Marc, Shah, Neel L, Gutierrez, Absalon Dennis, Guttenberg, Katie, Orlander, Philip R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207773/ http://dx.doi.org/10.1210/jendso/bvaa046.1381 |
Ejemplares similares
-
Ectopic ACTH syndrome – Experience with Etomidate*
por: Tong, Chin Voon, et al.
Publicado: (2017) -
THU531 A Case Of Cushing Syndrome Due To Ectopic ACTH Secreting Lung Neuroendocrine Tumor Treated With Cryoablation
por: Paknikar, Sujaytha, et al.
Publicado: (2023) -
MON-317 Ectopic Cushing's Syndrome Due to Prostate Cancer: A Case Series
por: Kanbour, Sarah, et al.
Publicado: (2019) -
MON-914 Ectopic ACTH Syndrome Caused by Adenocarcinoma of Lung - a Rare Association with Rare Complication
por: Tickoo, Vidya, et al.
Publicado: (2020) -
MON-178 Cyclical Cushing’s Syndrome in 12 Patients with Ectopic ACTH Secretion
por: Zenno, Anna, et al.
Publicado: (2020)